Author:
Chiu Wei Che,Tran Phat L.,Khalpey Zain,Lee Eric,Woo Yi-Ren,Slepian Marvin J.,Bluestein Danny
Funder
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. FDA. Thoratec HeartMate II LVAS - P060040/S005,
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm201473.htm
(2010).
2. FDA. HeartWare Ventricular Assist System - P100047,
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm330838.htm
(2012).
3. FDA. HeartMate 3 Left Ventricular Assist System (LVAS) - P160054/S008, https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm624155.htm (2018).
4. Slepian, M. J. et al. Shear-mediated platelet activation in the free flow: Perspectives on the emerging spectrum of cell mechanobiological mechanisms mediating cardiovascular implant thrombosis. J Biomech 50, 20–25,
https://doi.org/10.1016/j.jbiomech.2016.11.016
(2017).
5. Baumann Kreuziger, L. M. Management of anticoagulation and antiplatelet therapy in patients with left ventricular assist devices. J Thromb Thrombolysis 39, 337–344,
https://doi.org/10.1007/s11239-014-1162-6
(2015).
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献